You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Labeling Changes Promoting Safe Use of Long-Acting Opioids

Aschenbrenner, Diane S. MS, RN

AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000441788.62785.29
Drug Watch
Abstract

* The labeling of extended-release and long-acting opioid analgesics has been revised to warn practitioners that the drugs have been associated with misuse, abuse, life-threatening respiratory depression, accidental exposure, neonatal opioid withdrawal syndrome, and (with some drugs) serious drug interactions with alcohol.

* The labeling will also state that long-acting opioids should only be used if other pain relief methods aren't effective.

Author Information

Diane S. Aschenbrenner recently retired as course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: daschen1@jhu.edu.

© 2014 Lippincott Williams & Wilkins. All rights reserved.